At the exhibition, Diagreat presented its latest developments. With its innovative products, the company attracted the attention of many exhibitors. Among them, the Small molecule chemical drugs and biologics same-platform detection technology developed by Diagreat and the fully automated chemiluminescent immunoassay system, which is characterized by its high throughput and fully automated detection, attracted wide attention.

At the exhibition, Diagreat's products and technologies were highly evaluated by new and existing customer partners. Numerous attendees expressed great recognition of Diagreat's technological innovation and products. Through this exhibition, Diagreat not only demonstrated its strength, but also strengthened its connection with global customers, laying a solid foundation for future cooperation.